2nd Quarter - Report

FARRAGUT PARTNERS LLP for ASTRAZENECA PHARMACEUTICALS LP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2017 $30,000 Replaced
2nd Quarter - Amendment Oct 19, 2017 $40,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program

LobbyistCovered position, as disclosed
JEFF MACKINNON Prof Staff on E&C Cmte and LA Rep Whitfield
JEFFERY C. MORTIER LD & LA Rep. Joe Barton (RTexas)
J DANIEL WALSH LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 462 (115th)

Medicare/Medicaid MMM

Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE
J DANIEL WALSH LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
SARAH WALTER Former Legislative Director/Chief Counsel, Sen. John Breaux

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 462 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.